Sign In

Healthy Minds for Working Men: Early Identification and Prevention of Major Depression in Male Workers

Friday January 26, 2018 at 11:00 AM PT, 2:00 PM ET
Recorded in January 2018


Depression is prevalent in workplace and has a huge impact on employee health and productivity. Men are also vulnerable to depression and are less likely to seek help. There are many strategies for reducing the burden of workplace depression. The BroMatters project is a national project, aiming to identify and evaluate solution for early prevention of depression in men.
You will learn:
  • why depression is an important health issues in working men
  • what BroMatters entails, and
  • who are involved in BroMatters​

​  ​​

JianLi Wang, Ph.D.

Senior Scientist, Director. Work & Mental Health Research Unit, Institute of Mental Health Research

Dr. JianLi Wang is a Professor of the School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa. He holds the position of Senior Scientist and Director, Work & Mental Health Research Unit of the Institute of Mental Health Research affiliated with University of Ottawa. Prior to joining uOttawa in 2017, he was a Professor of the Departments of Psychiatry and of Community Health Sciences, University of Calgary. Dr. Wang received his PhD in Epidemiology at the University of Calgary.

Dr. Wang’s research interests are in two areas: workplace mental health and risk prediction analytics. In the domain of workplace mental health, Dr. Wang is leading a national team project on early identification and prevention of major depression in male workers, funded by Movember Foundation. This project is to develop and evaluate e-mental health program to be used by male workers to reduce the risk of having major depression. In the risk prediction research funded by the Canadian Institutes of Health Research, Dr. Wang’s team developed and validated the first sex-specific prediction algorithms for the risk of developing major depression in the general population. Presently his team is conducting a national randomized controlled trial to examine the benefits and potential psychological harms associated with disclosing personalized depression risk information to users.​


Last Modified: 1/26/2018 3:58 PM